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Abstract
Introduction
The prevalence of childhood asthma in the United States increased from 8.7% in 2001 to 9.5% in 2011. This increased 
prevalence adds to the costs incurred by state Medicaid programs. We provide state-based cost estimates of pediatric 
asthma emergency department (ED) visits and highlight an opportunity for states to reduce these costs through a 
recently changed Centers for Medicare and Medicaid Services (CMS) regulation.
Methods
We used a cross-sectional design across multiple data sets to produce state-based cost estimates for asthma-related ED 
visits among children younger than 18, where Medicaid/CHIP (Children’s Health Insurance Program) was the primary 
payer.
Results
There were approximately 629,000 ED visits for pediatric asthma for Medicaid/CHIP enrollees, which cost $272 
million in 2010. The average cost per visit was $433. Costs ranged from $282,000 in Alaska to more than $25 million 
in California.
Conclusions
Costs to states for pediatric asthma ED visits vary widely. Effective January 1, 2014, the CMS rule expanded which type 
of providers can be reimbursed for providing preventive services to Medicaid/CHIP beneficiaries. This rule change, in 
combination with existing flexibility for states to define practice setting, allows state Medicaid programs to reimburse 
for asthma interventions that use nontraditional providers (such as community health workers or certified asthma 
educators) in a nonclinical setting, as long as the service was initially recommended by a physician or other licensed 
practitioner. The rule change may help states reduce Medicaid costs of asthma treatment and the severity of pediatric 
asthma.
Introduction
Asthma is a chronic respiratory disease characterized by reversible periodic airway obstructions initiated by certain 
exposures, including environmental hazards (1). The disease is becoming increasingly prevalent in the United States, 
particularly among children and certain minority groups. More than 25 million people are currently diagnosed with the 
disease, including 6.5 million children younger than 18 (2). Although no cure for asthma is available, symptoms can be 
controlled with appropriate medical treatment, self-management, and education, and by avoiding exposure to 
environmental allergens and irritants that can trigger an attack (1).
Asthma in the United States costs $56 billion annually for direct health care expenditures and indirect costs such as 
lost productivity (3). In 2009, asthma resulted in approximately 480,000 hospitalizations, 1.9 million emergency 
department (ED) visits, and nearly 9 million doctors’ office visits (4). As the third leading cause of hospitalization 
among children younger than 15, asthma is associated with increased ED visits (5). Additionally, studies have reported 
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a higher rate of health care use among children insured by Medicaid compared with children insured by other health 
insurance programs (6).
Despite increased attention on asthma prevention and advances in diagnosis and treatment, childhood asthma 
prevalence in the United States has increased from 8.7% in 2001 to 9.5% in 2011 (7). Having a clinical care system that 
focuses on improving asthma management before cases become acute is essential. However, given the complexity of 
the disease, a comprehensive, community-based approach to educate and assist children with asthma outside of 
traditional clinical settings may be beneficial.
Asthma education programs provided in nontraditional settings, for example, in homes, can reinforce self-
management education and treatment by reaching children and parents where they live. These evaluated programs 
follow the National Asthma Education and Prevention Program evidence-based guidelines (1) that emphasize the need 
for asthma education at all points of care. Some studies have demonstrated that asthma home visitation programs may 
improve asthma management, reduce the number of missed school and work days, decrease allergens in the home, 
reduce urgent care use, and lessen caregiver stress (8,9). Furthermore, in its systematic review of research, the 
Community Preventive Services Task Force found that home-based interventions with an environmental focus 
improve the overall quality of life and productivity in children with asthma (10).
Despite the significant burden of pediatric asthma ED visits, we were unable to find comprehensive estimates of 
Medicaid and Children’s Health Insurance Program (CHIP) costs at the state level. We analyzed the cost of pediatric 
asthma ED visits, which are primarily paid for by Medicaid or CHIP at a state level. We then highlighted an 
opportunity for states to reduce asthma costs borne by their Medicaid programs because of a recent change to a 
Centers for Medicare and Medicaid Services (CMS) regulation. The rule change allows Medicaid to reimburse 
nontraditional health care providers for providing asthma prevention services in nontraditional settings.
Methods
Because data on pediatric asthma ED visits were not available for all states, we constructed a “second-best” 
approximation by using multiple sources of data that may not have included data from the same years. We chose the 
most recent data from each source to derive an estimate for a single year. We initially estimated the number of ED 
visits made by children aged 0 to 17 years where asthma was listed as one of the reasons for the visit and Medicaid or 
CHIP was the primary payer for the visit. For this part of the analysis, we used data from the National Hospital 
Ambulatory Medical Care Survey Emergency Department (NHAMCS-ED) survey.
The NHAMCS-ED is a national survey that collects information on the delivery and use of emergency care services at 
noninstitutional, general, and short-stay hospitals, excluding federal government facilities such as Veteran’s 
Administration hospitals and military hospitals in the states and the District of Columbia. This multistage design 
survey collects data on randomly selected patient records during a 4-week sampling period (11).
To analyze all ED visits for asthma by children younger than 18, we searched hospital records for International 
Classification of Diseases, 9th revision (ICD-9) codes to estimate the total visits in 2010. Each visit record contained up 
to 3 ICD-9 codes that contributed to the reason for the visit. We searched for the asthma code of 493.xx and its 
subcategories (493–493.92) among these 3 ICD-9 diagnosis codes. We further limited our search to visits for which 
Medicaid or CHIP was the primary payer. We considered all ED visits with any diagnosis of asthma, regardless of 
whether the patient was discharged home or admitted to the hospital.
State-by-state asthma prevalence data were obtained from the National Survey of Children’s Health (NSCH), 2012. 
This survey was sponsored by the Maternal and Child Health Bureau; the National Center for Health Statistics (NCHS) 
of the Centers for Disease Control and Prevention (CDC) oversaw the sampling. Data were collected by using the State 
and Local Area Integrated Telephone Survey (developed by NCHS) to randomly sample families from all 50 states and 
the District of Columbia. A total of 95,677 surveys were completed nationally for children aged 0 to 17 years, and a 
minimum of 1,800 surveys were collected for each state (12).
We used CMS enrollment data to determine the total number of children enrolled in state Medicaid/CHIP programs 
for each state. We obtained state-by-state enrollment data for children enrolled in Medicaid and CHIP in 2010 from 
the Kaiser Family Foundation website. The data provided in this report were available only for children aged 0 to 18 
(13). We multiplied state enrollment data by the prevalence data for each state to estimate the total number of children 
with asthma covered by Medicaid or CHIP. This data source did contain enrollment data on children aged 18, which is 
1 year older than the age range of 0 to 17 years for all other data sources used in these analyses. We were not able to 
adjust this number.
State estimates for the number of asthma ED visits for children younger than 18 were estimated by taking the total 
number of ED visits nationally (estimated by the NHAMCS-ED) and apportioning the visits to the states based on 
estimates of the number of Medicaid/CHIP enrollees with asthma in the state. For example, if a state covered 100,000 
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children under Medicaid/CHIP and had an asthma prevalence rate of 7%, we estimated that approximately 7,000 
(100,000 × 7%) children with asthma were covered by Medicaid/CHIP in that state. If these 7,000 children 
represented 5% of all children with asthma covered nationally by Medicaid/CHIP, then we assumed that this state had 
5% of all childhood asthma ED visits nationally.
We used Marketscan data to estimate the cost for pediatric asthma ED visits and subsequent hospitalizations. Costs for 
ED asthma visits and hospitalizations were obtained from the Marketscan Medicaid 2011 data set (the most recent year 
available). The Marketscan data set contains a convenience sample of claims data for Medicaid participants of 11 
unnamed states (14). We estimated costs by identifying children younger than 18 who were treated in the ED with 
asthma as either the primary diagnosis or 1 of 3 secondary diagnoses. Cost estimates were limited to cases where 
Medicaid was the expected payer, and the patient was enrolled in a noncapitated plan.
Results
According to NHAMCS-ED data, Medicaid/CHIP enrollees younger than 18 made an estimated 628,759 asthma-
related ED visits in 2010. Using the Marketscan Medicaid database, we estimated that the average cost per visit was 
$433. Given these estimates, pediatric asthma-related ED visits cost the Medicaid/CHIP programs a combined 
$272,453,850 in 2010.
Seven states (California, Florida, Georgia, Illinois, New York, Pennsylvania, and Texas) are estimated to have spent 
more than $10 million each in 2010 on asthma-related visits for this population (Figure, Table). California has a low 
prevalence of asthma (6.5%) but the highest cost because it covers a large number of enrollees. Other states, such as 
New York (10.5%) and Pennsylvania (10.9%), have higher prevalence than states of similar size, which contribute to 
higher asthma costs. For perspective, if the prevalence in New York had been the same as California’s, New York would 
have had 16,665 fewer asthma-related ED visits for this population and saved $7.2 million in 2010.
Figure. Medicaid/CHIP Spending on Asthma-Related Emergency Department Visits for Children Aged 0–17 Years, by 
State, 2010. Abbreviations: CHIP, Children’s Health Insurance Program; ED, emergency department. [A tabular 
version of this figure is also available.]
We estimated that 36 states had Medicaid/CHIP costs ranging from $1 million to $10 million for asthma-related 
pediatric ED visits. Among these states, Delaware, Alabama, Tennessee, Oklahoma, Mississippi, Kentucky, 
Connecticut, Rhode Island, Missouri, Massachusetts, and Louisiana had asthma prevalence above 10%. If a high-
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prevalence state such as Alabama (11.8%) had the same prevalence as Washington State (5.6%), Alabama could have 
eliminated about 6,763 ED visits for this population and saved $2.9 million in 2010.
Seven states and the District of Columbia had estimated Medicaid/CHIP costs under $1 million for asthma-related 
pediatric ED visits. Five (North Dakota, Montana, Alaska, South Dakota, and Wyoming) had low asthma prevalence 
(<8%) and fewer enrollees compared with other states. In contrast, the District of Columbia had a high asthma 
prevalence of 15.5%, and Vermont had an asthma prevalence of 8.6%. If the asthma prevalence for Vermont equaled 
that for South Dakota, Vermont could have eliminated 398 ED visits for this population and saved $172,602 in 2010 
(Figure, Table).
Discussion
Our analysis estimated that state Medicaid programs combined spent in excess of $272 million on pediatric asthma-
related ED visits in the United States in 2010. These results supplement data presented in the CDC Chronic Disease 
Calculator that provides estimates of the overall costs of asthma to states. Our data focuses specifically on pediatric ED 
visits, which are only a small portion of total asthma costs (15).
This research addresses a gap in the literature pertaining to Medicaid expenditures associated with pediatric asthma 
ED visits, costs that can be reduced through increased access to evidence-based interventions, including those 
provided in the home. To our knowledge, these estimates are the first of their type and could help state Medicaid 
directors and policy makers determine policy options for reducing costs of pediatric asthma.
Expanded coverage into nontraditional settings resulting in an uptake of preventive services could reduce asthma 
prevalence and asthma health disparities. Further research will better quantify whether reduced asthma-related costs 
result from nontraditional providers delivering services in home-based settings.
Home-based interventions can show a return on investment. The Community Preventive Services Task Force 
documented studies that demonstrated savings ranging from $5.30 to $14 for every dollar invested in home-based 
asthma interventions focused on children and adolescents. Community-based asthma interventions, including those 
provided in the home, help children proactively mitigate asthma triggers and help them manage asthma symptoms 
throughout their daily routines (16). A study of Boston’s Community Asthma Initiative (CAI) indicated that the 
program involving 283 children — which included home-based asthma education and other asthma services provided 
by community health workers — improved health outcomes and reduced ED visits, hospital admissions, missed school 
days, and parent work days (17). A related analysis found that “investments in a community asthma case management 
program can lead to large returns from the cost savings generated by the program” and that the CAI program was 
paying for itself within 2 years of implementation and was demonstrating cost savings after 3 years (18).
Innovative research projects being conducted by the New England Asthma Innovations Collaborative and funded by 
the Centers for Medicare and Medicaid Innovation (CMMI) are focusing on service delivery and payment systems for 
asthma. Those projects may also contribute to the evidence base for providing and paying for services that prevent 
asthma. That project is novel in exploring the spectrum of asthma preventive services in various settings, which are 
provided by both nonclinicians and clinicians and paid for by public or private insurance plans (19). Additional 
innovative projects would help us understand how payment mechanisms can influence health outcomes.
Effective January 1, 2014, CMS implemented an updated regulation (42 CFR section 440.130) regarding which 
providers can be reimbursed for providing preventive services to Medicaid and CHIP beneficiaries. Prior to January 1, 
2014, the regulation limited the coverage of preventable services to those that were actually provided by a physician or 
other licensed practitioner. As a result, some state Medicaid programs limited their coverage of preventive services to 
those furnished by licensed providers in a clinical setting. The regulation subsequently limited access to services and 
evidence-based interventions in homes and other community settings for Medicaid beneficiaries. In the final rule, CMS 
updated the regulation to allow state Medicaid programs to reimburse for preventive services provided by 
professionals such as community health workers or asthma educators so long as the service was initially recommended 
by a physician or other licensed practitioner (20). This change adds more flexibility to the Medicaid regulation that 
already allows states discretion over the setting in which care is provided. Thus, this final rule change on provider 
qualification, in combination with existing flexibility for states to define practice setting, can allow states to reimburse 
for asthma interventions that use nontraditional providers in a nonclinical setting.
Our estimates of asthma-related state ED visits covered by Medicaid and CHIP are subject to several limitations. One 
limitation is the different definition of “child” in different data sets used for our analysis. NSCH defines a child as being 
younger than 18 years, whereas our estimates of child enrollment in state Medicaid/CHIP programs include 18-year-
olds. Provided that the proportion of 18-year-old enrollees relative to the number of total childhood enrollees is similar 
between states, our estimates are unbiased. If a particular state has a larger number of 18-year-olds, the burden 
estimate for that state will be overestimated, and the burden estimate for other states will be underestimated. Our 
estimates also assume that the ED visit rate per childhood asthma enrollee is constant among states. If the ED visit 
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rate is lower in a particular state, then that state’s burden will be overestimated by our methods and other states’ 
burden would be underestimated.
Another limitation is that we identified our sample of visits by including the ICD code of 493.xx in any of the 3 possible 
codes related to the visit. Our approach may overestimate the numbers of visits directly caused by asthma. However, 
asthma was listed as a contributing factor to the visit. The clinician may also use a different ICD code such as 466.19 
for bronchitis before he or she actually determines the underlying cause of the condition. Therefore, these analyses 
would not include visits that include diagnoses that are related to asthma. These analyses focused on diagnosed 
asthma.
Finally, our cost estimates are based on the Marketscan Medicaid data set for 2011. This data set contains claims data 
for Medicaid enrollees in 11 unidentified participating states. Although the average cost for an asthma-related ED visit 
(and subsequent hospitalizations) is $433 for these states, individual states may have higher or lower asthma 
treatment costs because Medicaid payment rates vary by state and provider type (21). According to a 2009 report by 
New York State, the average cost to Medicaid managed care enrollees for an asthma-related ED visit in 2007 was $243 
(22). Therefore, we believe that the estimate taken from the 2011 Marketscan data is not out of reason. Furthermore, 
this estimate accounts for only the actual reimbursement by Medicaid for the ED visit, which is typically lower than 
reimbursements by other payers as well as lower than actual costs.
This analysis provides state-based estimates of costs for pediatric ED visits and brings attention to how much states 
are spending for this preventable condition. The CMS rule change described in this article may help states reduce costs 
of asthma treatment and at the same time reduce the severity of this condition through better management. Reduced 
costs for treating asthma may improve the overall quality of life and productivity for children and adolescents by 
improving asthma symptoms and reducing the number of school days missed due to asthma. We believe that the 
information presented here, despite its limitations, can be useful to policy makers in assessing options for decreasing 
Medicaid costs of asthma.
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Table
Table. Estimates of Asthma Prevalence, Medicaid/Children’s Health 
Insurance Program (CHIP) Enrollment, and Asthma-Related Pediatric 
Emergency Department (ED) Visits by State for US Children Aged 0–17 Years, 2010
State
Estimated 
Asthma 
Prevalence 
Among 
Children, %
Estimated No. of 
Children Covered 
by Medicaid/CHIP
Estimated No. of 
Medicaid/CHIP-
Covered Children 
with Asthma
Estimated No. of 
Asthma-Related ED 
Visits Covered by 
Medicaid/CHIP
Estimated Cost of 
Medicaid/CHIP 
Child ED Visits ($)
a b
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State
Estimated 
Asthma 
Prevalence 
Among 
Children, %
Estimated No. of 
Children Covered 
by Medicaid/CHIP
Estimated No. of 
Medicaid/CHIP-
Covered Children 
with Asthma
Estimated No. of 
Asthma-Related ED 
Visits Covered by 
Medicaid/CHIP
Estimated Cost of 
Medicaid/CHIP 
Child ED Visits ($)
Total 8.8 37,615,535 3,313,869 628,759 272,454,000 
AK 3.6 85,003 3,060 650 282,000
AL 11.8 585,768 69,121 12,873 5,578,000 
AR 8.0 455,683 36,455 5,483 2,376,000
AZ 8.7 720,427 62,677 13,652 5,916,000 
CA 6.5 5,614,747 364,959 58,200 25,219,000 
CO 8.7 444,142 38,640 10,271 4,451,000
CT 11.0 330,310 36,334 8,657 3,751,000
DC 15.5 88,179 13,667 1,505 652,000 
DE 12.0 98,380 11,805 2,379 1,031,000 
FL 9.9 2,151,703 213,019 38,166 16,538,000 
GA 10.0 1,321,941 132,194 24,001 10,400,000 
HI 9.9 137,057 13,569 2,897 1,256,000 
IA 5.8 315,976 18,326 4,067 1,762,000 
ID 6.1 166,424 10,152 2,521 1,093,000 
IL 8.5 1,738,547 147,776 25,622 11,102,000 
IN 9.9 765,624 75,797 15,338 6,646,000 
KS 8.3 264,408 21,946 5,812 2,519,000 
KY 11.2 507,771 56,870 11,041 4,784,000 
LA 10.1 765,634 77,329 10,877 4,713,000 
MA 10.2 635,442 64,815 13,942 6,041,000 
MD 9.6 574,712 55,172 12,512 5,422,000 
ME 8.2 141,526 11,605 2,169 940,000 
MI 8.4 1,219,772 102,461 18,967 8,219,000 
MN 7.1 451,077 32,026 8,782 3,806,000 
MO 10.2 654,024 66,710 14,006 6,069,000 
MS 11.4 469,395 53,511 8,297 3,595,000 
MT 6.4 96,432 6,172 1,378 597,000 
NC 9.2 1,132,557 104,195 20,221 8,762,000 
ND 7.6 48,808 3,709 1,097 475,000 
NE 6.8 188,248 12,801 3,008 1,303,000 
NH 9.3 107,748 10,021 2,573 1,115,000 
NJ 8.8 742,003 65,296 17,507 7,586,000 
NM 8.7 358,242 31,167 4,347 1,884,000 
NV 8.0 224,013 17,921 5,125 2,221,000 
NY 10.5 2,489,543 261,402 43,745 18,956,000 
OH 8.5 1,335,574 113,524 22,359 9,689,000 
a b
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State
Estimated 
Asthma 
Prevalence 
Among 
Children, %
Estimated No. of 
Children Covered 
by Medicaid/CHIP
Estimated No. of 
Medicaid/CHIP-
Covered Children 
with Asthma
Estimated No. of 
Asthma-Related ED 
Visits Covered by 
Medicaid/CHIP
Estimated Cost of 
Medicaid/CHIP 
Child ED Visits ($)
OK 11.4 559,482 63,781 10,209 4,424,000 
OR 7.7 380,566 29,304 6,427 2,785,000 
PA 10.9 1,274,545 138,925 29,317 12,704,000 
RI 10.9 112,099 12,219 2,352 1,019,000 
SC 8.5 540,188 45,916 8,847 3,834,000 
SD 5.4 92,841 5,013 1,055 457,000 
TN 11.5 860,553 98,964 16,573 7,181,000 
TX 8.1 3,699,623 299,669 53,572 23,214,000 
UT 5.8 246,406 14,292 4,867 2,109,000 
VA 9.0 671,413 60,427 16,071 6,964,000 
VT 8.6 72,805 6,261 1,071 464,000 
WA 5.6 796,010 44,577 8,531 3,696,000 
WI 8.7 596,145 51,865 11,226 4,864,000 
WV 9.9 223,847 22,161 3,695 1,601,000 
WY 6.9 62,172 4,290 900 390,000 
Childhood asthma prevalence is the weighted average of each state’s asthma prevalence total weighted by the number of 
covered children in the state and is not a nationally representative prevalence estimate.
These estimates have been rounded to the nearest $1,000.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. 
Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, 
or the authors' affiliated institutions.
a b
a
b
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